Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Phys Med ; 90: 53-65, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34562809

RESUMO

Improvements in delivery of radiation dose to target tissues in radiotherapy have increased the need for better image quality and led to a higher frequency of imaging patients. Imaging for treatment planning extends to function and motion assessment and devices are incorporated into medical linear accelerators (linacs) so that regions of tissue can be imaged at time of treatment delivery to ensure dose distributions are delivered as accurately as possible. A survey of imaging in 97 radiotherapy centres in nine countries on six continents has been undertaken with an on-line questionnaire administered through the International Commission on Radiological Protection mentorship programme to provide a snapshot of imaging practices. Responses show that all centres use CT for planning treatments and many utilise additional information from magnetic resonance imaging and positron emission tomography scans. Most centres have kV cone beam CT attached to at least some linacs and use this for the majority of treatment fractions. The imaging options available declined with the human development index (HDI) of the country, and the frequency of imaging during treatment depended more on country than treatment site with countries having lower HDIs imaging less frequently. The country with the lowest HDI had few kV imaging facilities and relied on MV planar imaging intermittently during treatment. Imaging protocols supplied by vendors are used in most centres and under half adapt exposure conditions to individual patients. Recording of patient doses, a knowledge of which is important in optimisation of imaging protocols, was limited primarily to European countries.


Assuntos
Radioterapia (Especialidade) , Radioterapia Guiada por Imagem , Tomografia Computadorizada de Feixe Cônico , Humanos , Aceleradores de Partículas , Imagens de Fantasmas , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Inquéritos e Questionários
2.
Epidemiol Infect ; 146(15): 1996-2002, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30056817

RESUMO

Circulating 25-hydroxy vitamin D (25(OH)D) is related to decreased rates of gastrointestinal and ear infections in school-age children. Vitamin D-binding protein (DBP) transports 25(OH)D and exerts immunological functions; however, it is unknown whether DBP is associated with infectious morbidity in children. We quantified plasma DBP concentrations in 540 school-age children at the time of recruitment into a cohort study in Bogotá, Colombia and obtained daily information on infectious morbidity symptoms and doctor visits during the school year. We compared the incidence rates of gastrointestinal and respiratory symptoms across quartiles of DBP concentration by estimating adjusted incidence rate ratios (IRRs) with 95% confidence interval (CI). We also estimated the per cent of the associations between DBP and morbidity that were mediated through 25(OH)D using a counterfactual frame. Mean ± s.d. DBP concentration was 2650 ± 1145 nmol/l. DBP was inversely associated with the rates of diarrhoea with vomiting (IRR for quartiles 2-4 vs. 1 = 0.48; 95% CI 0.25-0.92; P = 0.03) and earache/ear discharge with fever (IRR for quartiles 2-4 vs. 1 = 0.29; 95% CI 0.12-0.71; P = 0.006). The DBP-morbidity associations were not mediated through 25(OH)D. We conclude that plasma DBP predicts lower incidence of gastrointestinal and ear infections in school-age children independent of 25(OH)D.


Assuntos
Gastroenterite/epidemiologia , Otite/epidemiologia , Instituições Acadêmicas , Estudantes , Proteína de Ligação a Vitamina D/sangue , Criança , Pré-Escolar , Estudos de Coortes , Colômbia/epidemiologia , Feminino , Gastroenterite/imunologia , Humanos , Incidência , Masculino , Otite/imunologia , Plasma/química , Vitamina D/sangue
3.
J Appl Microbiol ; 123(2): 401-413, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28561275

RESUMO

AIMS: To isolate and identify TNT-transforming cultures from explosive-contaminated soils with the ability to produce biosurfactants. METHODS AND RESULTS: Bacteria (pure and mixed cultures) were selected based on their ability to transform TNT in minimum media with TNT as the sole nitrogen source and an additional carbon source. TNT-transforming bacteria were identified by 16S rRNA gene sequencing. TNT transformation rates were significantly lower when no additional carbon or nitrogen sources were added. Surfactant production was enabled by the presence of TNT. Fourteen cultures were able to transform the explosive (>50%); of these, five showed a high transformation capacity (>90%), and six produced surfactants. CONCLUSIONS: All explosive-transforming cultures contained Proteobacteria of the genera Achromobacter, Stenotrophomonas, Pseudomonas, Sphingobium, Raoultella, Rhizobium and Methylopila. These cultures transformed TNT when an additional carbon source was added. Remarkably, Achromobacter spanius S17 and Pseudomonas veronii S94 have high TNT transformation rates and are surfactant producers. SIGNIFICANCE AND IMPACT OF THE STUDY: TNT is a highly toxic, mutagenic and carcinogenic nitroaromatic explosive; therefore, bioremediation to eliminate or mitigate its presence in the environment is essential. TNT-transforming cultures that produce surfactants are a promising method for remediation. To the best of our knowledge, this is the first report that links surfactant production and TNT transformation by bacteria.


Assuntos
Bactérias/isolamento & purificação , Bactérias/metabolismo , Poluentes do Solo/metabolismo , Tensoativos/metabolismo , Trinitrotolueno/metabolismo , Bactérias/classificação , Bactérias/genética , Biodegradação Ambiental , Biotransformação , Carbono/metabolismo , Nitrogênio/metabolismo , Microbiologia do Solo
4.
Actas Dermosifiliogr ; 107(8): 674-80, 2016 Oct.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-27445129

RESUMO

BACKGROUND: Actinic keratoses (AKs) are common skin lesions associated with an increased risk of developing squamous cell carcinoma. Few studies in Europe have focused on AK prevalence. AIM: To determine the point prevalence of AKs in a dermatology outpatient population in Spain, to describe the clinical characteristics of these lesions and to characterise the profile of AK patients. METHODS: Observational, cross-sectional, multicentre study conducted in 19 hospitals (dermatology outpatient services) around Spain. A total of 204 consecutive patients per hospital who were ≥45 years old were screened for the presence of AKs. RESULTS: 3877 patients were assessed and the overall AKs prevalence was 28.6%. Prevalence was significantly higher in men than women (38.4% vs. 20.8%, p<0.0001) and increased with age for both sexes (45.2% in 71-80 years). Scalp and ear lesion locations were significantly more frequent in men (51.9% vs. 2.7% and 16.9% vs. 2.4%, respectively, p<0.0001 both cases) and the cheek, nose and neckline in women (46.3% vs. 34.0% [p<0.0001], 43.0% vs. 24.8% [p<0.0001] and 5.3% vs. 1.8% [p=0.002]). Men showed a significantly higher frequency of ≥2 affected areas than women (42.7% vs. 20.3%, p<0.0001). Among patients with AK lesions, only 65% confirmed that they were the reason for the visit to the clinic. CONCLUSIONS: Approximately a quarter of the dermatology outpatient population in Spain aged ≥45 years old have AKs, with the prevalence rate being highest in men and in older age groups. AK is underdiagnosed and a proactive strategy is needed for the diagnosis and early treatment of these lesions.


Assuntos
Dermatologia/estatística & dados numéricos , Ceratose Actínica/epidemiologia , Ambulatório Hospitalar/estatística & dados numéricos , Pacientes Ambulatoriais/estatística & dados numéricos , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Dermatoses Faciais/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Prevalência , Distribuição por Sexo
5.
BMC Genomics ; 17: 300, 2016 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-27108408

RESUMO

BACKGROUND: Solanum incanum is a close wild relative of S. melongena with high contents of bioactive phenolics and drought tolerance. S. aethiopicum is a cultivated African eggplant cross-compatible with S. melongena. Despite their great interest in S. melongena breeding programs, the genomic resources for these species are scarce. RESULTS: RNA-Seq was performed with NGS from pooled RNA of young leaf, floral bud and young fruit tissues, generating more than one hundred millions raw reads per species. The transcriptomes were assembled in 83,905 unigenes for S. incanum and in 87,084 unigenes for S. aethiopicum with an average length of 696 and 722 bp, respectively. The unigenes were structurally and functionally annotated based on comparison with public databases by using bioinformatic tools. The single nucleotide variant calling analysis (SNPs and INDELs) was performed by mapping our S. incanum and S. aethiopicum reads, as well as reads from S. melongena and S. torvum available on NCBI database (National Center for Biotechnology Information), against the eggplant genome. Both intraspecific and interspecific polymorphisms were identified and subsets of molecular markers were created for all species combinations. 36 SNVs were selected for validation in the S. incanum and S. aethiopicum accessions and 96 % were correctly amplified confirming the polymorphisms. In addition, 976 and 1,278 SSRs were identified in S. incanum and S. aethiopicum transcriptomes respectively, and a set of them were validated. CONCLUSIONS: This work provides a broad insight into gene sequences and allelic variation in S. incanum and S. aethiopicum. This work is a first step toward better understanding of target genes involved in metabolic pathways relevant for eggplant breeding. The molecular markers detected in this study could be used across all the eggplant genepool, which is of interest for breeding programs as well as to perform marker-trait association and QTL analysis studies.


Assuntos
Genes de Plantas , Solanum/genética , Transcriptoma , Mapeamento Cromossômico , Perfilação da Expressão Gênica , Ontologia Genética , Mutação INDEL , Repetições de Microssatélites , Melhoramento Vegetal , Polimorfismo de Nucleotídeo Único , RNA de Plantas/genética , Análise de Sequência de RNA , Solanum/classificação , Solanum melongena/genética
6.
Actas Dermosifiliogr ; 107(2): 142-8, 2016 Mar.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26363930

RESUMO

BACKGROUND AND OBJECTIVE: Hand eczema affects nearly 10% of the population. The condition becomes severe and chronic in 5% to 7% of cases and is refractory to topical corticosteroids in 2% to 4%. This study aimed to describe the current use of oral alitretinoin in treating Spanish national health system patients with hand eczema that is refractory to potent topical corticosteroids. MATERIALS AND METHODS: Observational, descriptive, exploratory, cross-sectional study based on the retrospective analysis of records for patients with hand eczema treated with alitretinoin in the Spanish national health system. RESULTS: We reviewed the records for 62 patients in 13 hospitals in 5 different administrative areas (autonomous communities) of Spain. Alitretinoin was usually used at a dosage of 30mg/d. In most cases the physician judged the clinical response to be satisfactory after a single cycle. The recorded adverse effects were foreseeable and of the type reported for systemic retinoids. The dermatologists agreed that the clinical benefits achieved with alitretinoin favored adherence to treatment and an early return to work. CONCLUSIONS: The results show that oral alitretinoin is being used according to established recommendations and that response is good, with few adverse effects. The dermatologists agreed that the benefits favored adherence and improved the patients' health related quality of life.


Assuntos
Eczema/tratamento farmacológico , Dermatoses da Mão/tratamento farmacológico , Tretinoína/uso terapêutico , Alitretinoína , Doença Crônica , Estudos Transversais , Humanos , Estudos Retrospectivos , Espanha , Tretinoína/administração & dosagem
7.
Eur J Clin Nutr ; 69(2): 167-72, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25271016

RESUMO

BACKGROUND/OBJECTIVES: Studies in adults indicate that dietary polyunsaturated fatty acid (PUFA) composition may play a role in development of adiposity. Because adipocyte quantity is established between late childhood and early adolescence, understanding the impact of PUFAs on weight gain during the school-age years is crucial to developing effective interventions. SUBJECTS/METHODS: We quantified N-3 and N-6 PUFAs in serum samples of 668 Colombian schoolchildren aged 5-12 years at the time of recruitment into a cohort study, using gas-liquid chromatography. Serum concentrations of N-3 (alpha-linolenic acid (ALA), eicosapentaenoic acid, docosahexaenoic acid) and N-6 PUFAs (linoleic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, arachidonic acid) were determined as percentage total fatty acids. Children's anthropometry was measured annually for a median of 30 months. We used mixed-effects models with restricted cubic splines to construct population body mass index-for-age z-score (BAZ) growth curves for age- and sex-specific quartiles of each PUFA. RESULTS: N-3 ALA was inversely related to BAZ gain after adjustment for sex, baseline age and weight status, as well as household socioeconomic level. Estimated BAZ change between 6 and 14 years among children in the highest quartile of ALA compared with those in the lowest quartile was 0.45 (95% confidence interval: 0.07, 0.83) lower (P-trend=0.006). CONCLUSIONS: N-3 ALA may be protective against weight gain in school-age children. Whether improvement in PUFA status reduces adiposity in pediatric populations deserves evaluation in randomized trials.


Assuntos
Índice de Massa Corporal , Dieta , Ácidos Graxos/sangue , Estado Nutricional , Obesidade Infantil/prevenção & controle , Aumento de Peso/efeitos dos fármacos , Ácido alfa-Linolênico/sangue , Adiposidade/efeitos dos fármacos , Criança , Pré-Escolar , Estudos de Coortes , Colômbia , Gorduras na Dieta/sangue , Gorduras na Dieta/farmacologia , Gorduras na Dieta/uso terapêutico , Ácidos Graxos/farmacologia , Ácidos Graxos/uso terapêutico , Feminino , Humanos , Masculino , Obesidade Infantil/sangue , Ácido alfa-Linolênico/farmacologia , Ácido alfa-Linolênico/uso terapêutico
8.
Eur J Clin Nutr ; 67(6): 646-51, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23462945

RESUMO

BACKGROUND: Studies regarding the role of iron on linear growth have yielded heterogeneous results. Some trials indicate that iron supplementation of iron-replete infants leads to slower-length gain. However, little is known of the relation between iron status and linear growth in school-age children. METHODS: We quantified plasma ferritin, mean corpuscular volume (MCV), and hemoglobin in 2714 children aged 5-12 years at recruitment into a cohort study. Height was measured periodically for a median of 30 months. Height-for-age Z-scores (HAZ) were calculated using the World Health Organization growth reference. Mixed effects models with restricted cubic splines were used to construct population HAZ-for-age growth curves for sex- and age-specific quartiles of each iron status indicator. RESULTS: Ferritin and MCV were each inversely related to attained HAZ among boys after the adjustment for baseline age, baseline body mass index-for-age Z-score and socioeconomic status. There was a decreasing monotonic relation between quartiles of ferritin and estimated change in HAZ from ages 6 to 14 years (P trend=0.001); boys in the 4th quartile experienced a HAZ change that was 0.46 Z lower than that of boys in the 1st quartile (P=0.0006). Similarly, we observed smaller HAZ change among boys in the highest quartile of MCV in comparison with those in the 1st quartile (P trend=0.001). Hemoglobin was not related to linear growth in boys. None of the iron-status indicators were associated with linear growth in girls. CONCLUSIONS: Higher iron status, as indicated by ferritin and MCV, is related to slower linear growth in iron-replete school-age boys.


Assuntos
Estatura , Desenvolvimento Infantil , Transtornos do Crescimento/etiologia , Ferro da Dieta/efeitos adversos , Estado Nutricional , Anemia Ferropriva/sangue , Anemia Ferropriva/epidemiologia , Criança , Pré-Escolar , Estudos de Coortes , Colômbia/epidemiologia , Feminino , Seguimentos , Alimentos Fortificados/efeitos adversos , Transtornos do Crescimento/epidemiologia , Transtornos do Crescimento/fisiopatologia , Humanos , Sobrecarga de Ferro/sangue , Sobrecarga de Ferro/epidemiologia , Sobrecarga de Ferro/etiologia , Sobrecarga de Ferro/fisiopatologia , Ferro da Dieta/administração & dosagem , Estudos Longitudinais , Masculino , Política Nutricional , Prevalência , Estudos Prospectivos , Índice de Gravidade de Doença , Caracteres Sexuais
9.
Rev. neurol. (Ed. impr.) ; 54(11): 641-648, 1 jun., 2012. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-100092

RESUMO

Introducción. Los pacientes con migraña refieren con frecuencia factores o circunstancias que precipitan o desencadenansus crisis. A pesar de ello, son muy escasos los estudios realizados al efecto. Objetivo. Explorar los factores precipitantes de crisis de migraña en nuestro medio, así como su posible relación con laintensidad de las crisis o la repercusión global de la migraña. Pacientes y métodos. Estudio epidemiológico, transversal y multicéntrico realizado en consultas de neurología. Se recogierondatos sociodemográficos y clínicos, así como los factores precipitantes identificados de un listado cerrado. Se utilizaron el cuestionario de discapacidad específico para migraña -Headache Impact Test (HIT-6)- y la medida del número de días equivalentes a días de trabajo perdidos. Resultados. Se reclutaron 817 pacientes (72,5% mujeres; edad media: 34,6 ± 10,3 años). El 70,5% de los pacientes tenía un grado de discapacidad grave según el HIT-6. La media mensual de días equivalentes a días de trabajo perdidos fue de 2,1 ± 2,5. Un 96,6% de los pacientes identificó algún factor precipitante de crisis, siendo los más frecuentemente comunicadoslos hormonales (75,2%), el estrés (70,9%) y los relacionados con las alteraciones en el patrón de sueño (68,4%). Conclusiones. El estudio FACTOR confirma que la mayoría de pacientes con migraña identifica alguna circunstancia precipitantede sus crisis. El control o evitación de estos factores, en los casos en que sea posible, debe formar parte del programa de educación del paciente con migraña (AU)


Introduction. Patients with migraine often report factors or circumstances that precipitate or trigger their attacks. Yet fewstudies have been conducted to examine this matter. Aim. To explore the factors that precipitate migraine in our setting, as well is their possible relation with the intensity ofthe attacks or the overall repercussion of migraine.Patients and methods. An epidemiological, cross-sectional, multi-centre study was conducted in neurology consultation services. Sociodemographic and clinical data were collected and the precipitating factors were identified from a closed list. The specific migraine disability questionnaire -Headache Impact Test (HIT-6)- and the measurement of the number of lost workday equivalents were used in the study.Results. Altogether 817 patients were recruited (72.5% females, mean age: 34.6 ± 10.3 years). A total of 70.5% of the patients had severe disability according to the HIT-6. The mean monthly number of lost workday equivalents was 2.1 ± 2.5. A total of 96.6% of the patients identified some precipitating factor for the attacks, the most commonly reported being hormonal (75.2%), stress (70.9%) and those related with disorders affecting sleep patterns (68.4%). Conclusions. The FACTOR study confirms that most patients with migraine identify some circumstance that precipitatestheir attacks. Controlling or avoiding these factors, whenever possible, must be part of the programme of education received by patients suffering from migraine (AU)


Assuntos
Humanos , Transtornos de Enxaqueca/etiologia , Cefaleia/complicações , Fatores de Risco , Estresse Psicológico/complicações , Avaliação da Deficiência
10.
Rev Neurol ; 54(11): 641-8, 2012 Jun 01.
Artigo em Espanhol | MEDLINE | ID: mdl-22627745

RESUMO

INTRODUCTION: Patients with migraine often report factors or circumstances that precipitate or trigger their attacks. Yet few studies have been conducted to examine this matter. AIM: To explore the factors that precipitate migraine in our setting, as well is their possible relation with the intensity of the attacks or the overall repercussion of migraine. PATIENTS AND METHODS: An epidemiological, cross-sectional, multi-centre study was conducted in neurology consultation services. Sociodemographic and clinical data were collected and the precipitating factors were identified from a closed list. The specific migraine disability questionnaire -Headache Impact Test (HIT-6)- and the measurement of the number of lost workday equivalents were used in the study. RESULTS: Altogether 817 patients were recruited (72.5% females, mean age: 34.6 ± 10.3 years). A total of 70.5% of the patients had severe disability according to the HIT-6. The mean monthly number of lost workday equivalents was 2.1 ± 2.5. A total of 96.6% of the patients identified some precipitating factor for the attacks, the most commonly reported being hormonal (75.2%), stress (70.9%) and those related with disorders affecting sleep patterns (68.4%). CONCLUSIONS: The FACTOR study confirms that most patients with migraine identify some circumstance that precipitates their attacks. Controlling or avoiding these factors, whenever possible, must be part of the programme of education received by patients suffering from migraine.


Assuntos
Transtornos de Enxaqueca/etiologia , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Transtornos de Enxaqueca/epidemiologia , Fatores Desencadeantes
11.
Gastroenterol. hepatol. (Ed. impr.) ; 35(1): 1-7, ene. 2012.
Artigo em Espanhol | IBECS | ID: ibc-98677

RESUMO

Las complicaciones gastrointestinales (GI) son un efecto secundario habitual relacionado con el uso de antiinflamatorios no esteroideos (AINE) y aspirina a dosis bajas (ADB). Las directrices para prevenir las complicaciones GI establecen que los pacientes con elevado riesgo deben recibir alguna forma de protección gástrica. Sin embargo, diversos informes sugieren que dichas estrategias no se llevan a cabo. Para determinar la prevalencia en la atención primaria española del uso de estrategias preventivas para reducir las complicaciones GI en los pacientes a los que se les ha prescrito AINE y ADB, se realizó un estudio observacional, transversal y multicéntrico en el que participaron médicos de atención primaria. Desde enero a mayo de 2009, los médicos recogieron datos demográficos, clínicos y sobre tratamiento procedentes de la última visita en 2008 de los 5 primeros pacientes consecutivos que cumplían los criterios de selección. Se llevó a cabo una regresión logística multivariante para identificar los predictores independientes de las estrategias preventivas utilizadas. Un total de 713 médicos de atención primaria incluyeron a 3357 pacientes: el 68% tomaba AINE, el 19,1% ADB y el 12,9% recibía AINE y ADB. El 31,5% de los pacientes no presentaba factores de riesgo de complicaciones GI, el 25,6% tenia uno y el 42,9% 2 o más factores de riesgo. La prevalencia total de uso de estrategias de prevención fue del 75,8%. La prevalencia del uso de gastroprotección incrementó con el número de factores de riesgo. La infrautilización de protección GI en pacientes con alto riesgo tratados con AINE es baja y no es tan marcada como la que se notifica en la atención primaria de otros países. También se observó un uso elevado de gastroprotección en los pacientes que toman ADB (AU)


Gastrointestinal (GI) complications are common side effects related to non-steroidal anti-inflammatory drugs (NSAID) and low-dose aspirin (LDA) use. The guidelines to prevent GI complications establish that patients at high risk should receive gastroprotection. However, different reports have suggested that these strategies are not greatly executed. To determine the prevalence of use of preventive strategies to reduce GI complications in NSAID and/or LDA users in primary care in Spain, we performed an observational, cross-sectional, multicentre study in which primary care physicians from Spain participated. From January 2009 to May 2009, physicians collected demographic, clinical and treatment data from the last visit in 2008 of the first 5 consecutive patients who met the selection criteria. A multivariate logistic regression was carried out to identify independent predictors of the preventive strategies used. A total of 713 primary care physicians included 3357 patients: 68% NSAID users, 19.1% LDA users and 12.9% NSAID/LDA users. 31.5% of patients did not have a risk factor for GI complications, 25.6% had one risk factor and 42.9% had 2 or more risk factors. The overall prevalence of preventive strategy use was 75.8%. The prevalence of gastroprotection use increased with the number of risk factors. The underutilization of gastroprotection in at-risk patients treated with NSAIDs is low and not as marked as those previously reported at the primary care level in other countries. We also found high rates of gastroprotection use in LDA users (AU)


Assuntos
Humanos , Anti-Inflamatórios não Esteroides/efeitos adversos , Aspirina/efeitos adversos , Gastrite/induzido quimicamente , Conduta do Tratamento Medicamentoso/estatística & dados numéricos , Inibidores da Bomba de Prótons/uso terapêutico , /prevenção & controle
12.
Nutr Metab Cardiovasc Dis ; 22(3): 244-51, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20705440

RESUMO

BACKGROUND AND AIMS: To examine the cross-sectional associations of inflammatory markers in plasma including C-reactive protein (CRP) and ferritin, and white blood cell (WBC) count, with overweight, skinfold sum (subscapular + triceps), and skinfold ratio (subscapular/triceps) among children from Bogotá, Colombia. METHODS AND RESULTS: The sample (n = 2614) represented low- and middle-income children, aged 5-12 years, from Bogotá. We assessed their anthropometry, sociodemographic characteristics, and circulating inflammatory markers. We defined overweight, including obesity, according to the International Obesity Task Force BMI criteria. After adjustment for potential confounders, children in the fourth quartile of the CRP distribution had a 37% higher prevalence of overweight compared to those in the first quartile (P for trend = 0.03); and children in the fourth quartile of ferritin had a 67% greater prevalence of overweight compared to children in the first quartile (P for trend <0.001). Children in the highest 3 quartiles of the WBC distribution had a 35% higher prevalence of overweight than those in the first quartile (P = 0.03). Ferritin was significantly and positively associated with skinfold sum (P for trend < 0.001), while WBC was significantly and positively associated with skinfold ratio (P for trend < 0.001). There was a significant interaction between CRP and ferritin; children in the highest quartiles of CRP and ferritin had twice the prevalence of overweight compared to those below the highest quartiles (P = 0.001). CONCLUSION: Biomarkers of chronic inflammation are positively associated with child overweight. WBC is positively related to skinfold ratio, a proxy for truncal adiposity.


Assuntos
Inflamação/epidemiologia , Sobrepeso/epidemiologia , Adiposidade , Idade de Início , Biomarcadores/sangue , Proteína C-Reativa/análise , Criança , Pré-Escolar , Doença Crônica , Colômbia/epidemiologia , Estudos Transversais , Feminino , Ferritinas/sangue , Humanos , Inflamação/sangue , Inflamação/diagnóstico , Mediadores da Inflamação/sangue , Leucócitos , Masculino , Sobrepeso/diagnóstico , Sobrepeso/fisiopatologia , Prevalência , Análise de Regressão , Medição de Risco , Fatores de Risco , Dobras Cutâneas
13.
Gastroenterol Hepatol ; 35(1): 1-7, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22178503

RESUMO

Gastrointestinal (GI) complications are common side effects related to non-steroidal anti-inflammatory drugs (NSAID) and low-dose aspirin (LDA) use. The guidelines to prevent GI complications establish that patients at high risk should receive gastroprotection. However, different reports have suggested that these strategies are not greatly executed. To determine the prevalence of use of preventive strategies to reduce GI complications in NSAID and/or LDA users in primary care in Spain, we performed an observational, cross-sectional, multicentre study in which primary care physicians from Spain participated. From January 2009 to May 2009, physicians collected demographic, clinical and treatment data from the last visit in 2008 of the first 5 consecutive patients who met the selection criteria. A multivariate logistic regression was carried out to identify independent predictors of the preventive strategies used. A total of 713 primary care physicians included 3357 patients: 68% NSAID users, 19.1% LDA users and 12.9% NSAID/LDA users. 31.5% of patients did not have a risk factor for GI complications, 25.6% had one risk factor and 42.9% had 2 or more risk factors. The overall prevalence of preventive strategy use was 75.8%. The prevalence of gastroprotection use increased with the number of risk factors. The underutilization of gastroprotection in at-risk patients treated with NSAIDs is low and not as marked as those previously reported at the primary care level in other countries. We also found high rates of gastroprotection use in LDA users.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Aspirina/efeitos adversos , Gastroenteropatias/induzido quimicamente , Gastroenteropatias/prevenção & controle , Padrões de Prática Médica , Atenção Primária à Saúde , Idoso , Estudos Transversais , Feminino , Gastroenteropatias/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
14.
Plant Dis ; 96(12): 1819, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30727295

RESUMO

Stewart's wilt is a serious disease of corn (Zea mays L.) caused by the bacterium Pantoea stewartii subsp. stewartii (Pss). Typical symptoms of infected fields and dent corn are longitudinal streaks with irregular or wavy margins, which are parallel to the veins and may extend the length of the leaf. These pale to green yellow lesions become dry and brown as the disease progresses producing a leaf blight (4). During the growing seasons 2010 to 2011 and 2011 to 2012, symptoms of bacterial leaf blight of corn were observed in central Argentina maize fields, with an incidence of 54% in Córdoba province. To identify the pathogen, leaves from 10 symptomatic maize plants per field were collected from 15 fields covering a representative geographical area. High populations of morphologically uniform bacteria were isolated from leaf tissues by conventional methods using King's medium B agar (2). Ten representative facultatively anaerobic gram-negative, non-fluorescing, non-motile, catalase positive and oxidase negative rod-shaped and yellow-pigmented bacterial isolates were evaluated further. The biochemical profile obtained was: fermentative metabolism, negative indol, acetoin and hydrogen sulfide production, negative gelatin hydrolysis (22°C), positive acid production from D-glucose and lactose, negative gas production from D-glucose, and negative nitrate reduction (1). All the isolates produced a 300-bp band with PCR using the species specific primer pair PST3581/PST3909c (3). The Pss ATCC 8199 and Pseudomonas fluorescens ATCC 13525 strains were used as positive and negative controls for the PCR assays, respectively. The pathogenicity test was performed by stem inoculation of five to ten P2069 YR maize plants (one to two leaf growth stage) grown in growth chamber. Plants were inoculated by syringe with a 107 to 108 cell/ml bacterial suspension and kept in a humid chamber at 25 to 27°C. Plants inoculated with Pss ATCC 8199 or with sterile water were used as positive and negative control treatments, respectively. The development of symptoms similar to those originally found in the field was observed on all the plants inoculated with the different isolates at 7 to 10 days post inoculation. In addition, symptoms on inoculated plants were similar to those observed for the positive control treatment. No symptoms were found on negative controls. Koch's postulates were fulfilled since bacteria isolated from symptomatic tissue had identical characteristics to isolates used to inoculate plants and to the reference Pss strain for biochemical tests and PCR reaction mentioned above. To our knowledge, this is the first report of P. stewartii subsp. stewartii isolated from diseased maize in Argentina. References: (1) J. G. Holt et al. Page 179 in: Bergey's manual of determinative bacteriology. Williams and Wilkins, Baltimore, MD, 1994. (2) OEPP/EPPO. Bulletin OEPP/EPPO Bulletin, 36: 111, 2006. Pantoea stewartii subsp. stewartii diagnostic. (3) A. Wensing et al. Appl. Environ. Microbiol. 76:6248, 2010. (4) D. G. White Page 4 in: Compendium of corn disease. The American Phytopathology Society, 1999.

15.
Gastroenterol. hepatol. (Ed. impr.) ; 32(10): 669-676, dic. 2009. ilus, graf, tab
Artigo em Espanhol | IBECS | ID: ibc-85454

RESUMO

Introducción/objetivosLa dispepsia funcional es un trastorno muy frecuente, cuyos mecanismos fisiopatológicos todavía no son bien conocidos y sobre la que los procinéticos parecen tener utilidad. El objetivo del presente estudio fue evaluar el efecto procinético de cinitaprida en pacientes con dispepsia funcional tipo dismotilidad y enlentecimiento del vaciamiento gástrico.MétodosDe forma aleatoria, 19 pacientes recibieron 1mg de una solución oral de cinitaprida t.i.d. o placebo durante 4 semanas en dos periodos consecutivos, según un diseño cruzado y a doble ciego. La variable principal fue la media del cambio en el tiempo de vaciamiento gástrico a la mitad respecto al valor basal tras ingesta líquida, a las 4 semanas de tratamiento, cuantificado mediante ecografía de alta resolución en tiempo real.ResultadosAl finalizar el tratamiento, la media del tiempo de vaciamiento gástrico a la mitad disminuyó para ambos tratamientos, sin diferencias estadísticamente significativas entre ellos (p=0,8720). Esta disminución resultó mayor para cinitaprida respecto a placebo (p=0,0169) cuando se analizó a los pacientes con un vaciamiento de leve a moderadamente enlentecido. Para este grupo de pacientes, cinitaprida resultó estadísticamente superior a placebo en el área bajo la curva porcentual del área antral y en el porcentaje de días libres de náuseas. La administración de cinitaprida fue bien tolerada, con un perfil de seguridad comparable a placebo.ConclusionesCinitaprida oral es segura, facilita el vaciamiento gástrico y mejora la sintomatología clínica en pacientes con dispepsia funcional tipo dismotilidad y enlentecimiento del vaciamiento gástrico leve-moderado (AU)


Introduction and objectiveFunctional dyspepsia is a highly common disorder. The physiopathological mechanisms of this entity are not yet completely known and prokinetic drugs seem to be useful. The aim of this study was to evaluate the prokinetic effect of cinitapride in patients with dysmotility-like dyspepsia and delayed gastric emptying.MethodsNineteen patients were randomized to receive 1mg of an oral solution of cinitapride t.i.d or placebo for 4 weeks in two consecutive periods, following a crossover and double-blind design. The main variable was the mean change from baseline after 4 weeks of treatment in gastric-emptying half-time after a liquid test meal, measured by real-time ultrasonography.ResultsAt the end of treatment, the mean gastric-emptying half-time decreased with both treatments, with no statistically significant differences between them (ANOVA, p=0.8720). This decrease was greater for cinitapride than for placebo (ANOVA, p=0.0169) in patients with mild-to-moderate delayed gastric emptying. In this group of patients, cinitapride was also superior to placebo in the percentage AUC of the antral area and the percentage of days free of nausea. Cinitapride was well tolerated, with a safety profile comparable to that of placebo.ConclusionsOral cinitapride is safe and effective in improving gastric emptying and symptoms in patients with dysmotility-like dyspepsia and mild-to-moderate delayed gastric emptying(AU)


Assuntos
Humanos , Dispepsia/tratamento farmacológico , Fármacos Gastrointestinais/farmacocinética , Esvaziamento Gástrico , Placebos/uso terapêutico , Inibidores da Bomba de Prótons/uso terapêutico , Domperidona/uso terapêutico , Cisaprida/uso terapêutico
16.
Gastroenterol Hepatol ; 32(10): 669-76, 2009 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-19819042

RESUMO

INTRODUCTION AND OBJECTIVE: Functional dyspepsia is a highly common disorder. The physiopathological mechanisms of this entity are not yet completely known and prokinetic drugs seem to be useful. The aim of this study was to evaluate the prokinetic effect of cinitapride in patients with dysmotility-like dyspepsia and delayed gastric emptying. METHODS: Nineteen patients were randomized to receive 1mg of an oral solution of cinitapride t.i.d or placebo for 4 weeks in two consecutive periods, following a crossover and double-blind design. The main variable was the mean change from baseline after 4 weeks of treatment in gastric-emptying half-time after a liquid test meal, measured by real-time ultrasonography. RESULTS: At the end of treatment, the mean gastric-emptying half-time decreased with both treatments, with no statistically significant differences between them (ANOVA, p=0.8720). This decrease was greater for cinitapride than for placebo (ANOVA, p=0.0169) in patients with mild-to-moderate delayed gastric emptying. In this group of patients, cinitapride was also superior to placebo in the percentage AUC of the antral area and the percentage of days free of nausea. Cinitapride was well tolerated, with a safety profile comparable to that of placebo. CONCLUSIONS: Oral cinitapride is safe and effective in improving gastric emptying and symptoms in patients with dysmotility-like dyspepsia and mild-to-moderate delayed gastric emptying.


Assuntos
Benzamidas/uso terapêutico , Dispepsia/tratamento farmacológico , Esvaziamento Gástrico/efeitos dos fármacos , Gastroparesia/tratamento farmacológico , Agonistas do Receptor 5-HT4 de Serotonina , Serotoninérgicos/uso terapêutico , Adulto , Idoso , Benzamidas/efeitos adversos , Benzamidas/farmacologia , Sistemas Computacionais , Estudos Cross-Over , Antagonistas dos Receptores de Dopamina D2 , Método Duplo-Cego , Eletrocardiografia/efeitos dos fármacos , Feminino , Gastroparesia/diagnóstico por imagem , Gastroparesia/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Antro Pilórico/diagnóstico por imagem , Antro Pilórico/fisiopatologia , Antagonistas do Receptor 5-HT2 de Serotonina , Serotoninérgicos/efeitos adversos , Serotoninérgicos/farmacologia , Ultrassonografia , Adulto Jovem
17.
Eur J Clin Nutr ; 63(7): 842-9, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18957973

RESUMO

BACKGROUND: While the majority of cases of nutritional anemia in developing countries are caused by iron deficiency, other micronutrient deficiencies may also be involved. In Colombia, it was recently reported that 38% of school children were anemic; yet, the rate of iron deficiency was only 3.6%. OBJECTIVE: To determine if micronutrients other than iron were responsible for low hemoglobin concentrations in Colombian school children. METHODS: We examined hemoglobin concentrations in relation to plasma ferritin, vitamin A, vitamin B12, and erythrocyte folate levels in a representative sample of 2812 low- and middle-income children (5-12 years) from Bogotá, Colombia. RESULTS: In multivariate analysis, hemoglobin concentration was positively associated with child's age, mother's age, household's socioeconomic stratum, and family income. Low ferritin was related to 3.6 g/l lower hemoglobin concentration (95% confidence interval=-6.0, -1.3). Unexpectedly, we found an inverse trend in hemoglobin concentration by quartiles of erythrocyte folate; the adjusted hemoglobin concentration difference between the highest and lowest folate quartiles was -6.0 g/l (95% confidence interval=-7.2, -4.9; P for trend <0.0001). This difference was greatest among children with vitamin B12 concentration <148 pmol/l (-11.5 g/l), followed by children with vitamin B12 concentration 148-221 pmol/l (-7.7 g/l), and smallest in children with vitamin B12 concentration >221 pmol/l (-5.7 g/l); P for interaction=0.04. CONCLUSIONS: Hemoglobin concentration is inversely related to erythrocyte folate concentrations in a setting where folate fortification was adopted more than a decade ago. The impact of improving vitamin B12 status on this inverse relationship should be examined.


Assuntos
Anemia/embriologia , Ácido Fólico/sangue , Hemoglobinas/análise , Vitamina B 12/sangue , Anemia/prevenção & controle , Criança , Pré-Escolar , Colômbia/epidemiologia , Estudos Transversais , Eritrócitos/química , Feminino , Ferritinas/sangue , Humanos , Masculino , Vitamina A/sangue
18.
J Hum Nutr Diet ; 21(1): 63-71, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18184395

RESUMO

BACKGROUND: Epidemiological evidence suggests that populations with high fruit and vegetable (FV) consumption have a lower risk for childhood obesity, cancer and cardiovascular diseases. There are no studies that address the correlates of FV intake in Mexican children; therefore, the aim of this study was to identify the frequency of FV consumption by children in Mexico City's low income state schools and their personal (preferences, expectancy, knowledge and self-efficacy) and environmental (accessibility and person in charge of cooking at home) correlates. METHODS: A validated questionnaire to assess accessibility, expectancy, self-efficacy, preference and knowledge; and a 2-day dietary recall were used to assess the FV intake and its correlates in 327 children. Statistical analysis included chi-square and stepwise logistic regression. RESULTS: Average consumption of FV was once a day with a higher proportion of girls consuming FV 3 or more times per day (15.2% versus 6.7%; P < 0.01). The environmental factors that influenced a higher consumption of FV were the mother being responsible for cooking at home (P < 0.02) and accessibility to FV (P < 0.01); whereas the personal factors were self-efficacy (P < 0.05) and preference (P < 0.03) to vegetables. CONCLUSION: Correlates of fruit and vegetable consumption in children from Mexico City's State Schools were being female and accessibility to fruits and vegetables. Home and school environments are decisive for the children to increase FV consumption. Creative ways to encourage FV consumption in boys should be explored. These factors should be considered when designing programmes aimed at increasing consumption of fruits and vegetables in children.


Assuntos
Inquéritos sobre Dietas , Preferências Alimentares , Abastecimento de Alimentos , Frutas , Verduras , Criança , Fenômenos Fisiológicos da Nutrição Infantil , Comportamento Alimentar , Feminino , Frutas/economia , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Modelos Logísticos , Masculino , México , Autoeficácia , Distribuição por Sexo , Fatores Socioeconômicos , Inquéritos e Questionários , População Urbana/estatística & dados numéricos , Verduras/economia
19.
Curr Med Res Opin ; 24(2): 569-76, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18194594

RESUMO

OBJECTIVE: To evaluate the pharmacological compliance of patients treated with lansoprazole orally disintegrating tablets (LODT) in Primary Care (PC) and their acceptability of this formulation. RESEARCH DESIGN AND METHODS: A multicenter, observational, cross-sectional study involving 433 PC physicians that included 433 patients aged at least 18 years, either diagnosed with gastroesophageal reflux disease (GERD) or taking LODT to prevent NSAID-induced gastric ulcers. Compliance with LODT treatment was assessed with the Haynes-Sackett self-reported test. Acceptability was based on global patient assessment, rating the drug's organoleptic characteristics and properties recorded with a self-administered 15-item ad hoc questionnaire with 2 and 5-point Likert-type scales. RESULTS: 423 patients (mean age 50.6 years, SD = 13.4) were evaluable for the main endpoint. Of these, 57.16% were men and 53.5% were treated with 30 mg doses of LODT for an average of 37.8 days (SD = 35.5). Compliance was achieved by 92.4% of the patients, mean percentage of compliance was 93.3. Demographical and clinical variables had no effect on compliance. Treatment with LODT was assessed as 'acceptable' or 'highly acceptable' by 91.7% of the sample. One adverse reaction, not serious, was reported by one patient (0.2%). CONCLUSIONS: In this observational study, compliance with lansoprazole orally disintegrating tablets was very high. Patients reported that this formulation improved their compliance. LODT was clearly preferred to previous medication and the drug was well tolerated.


Assuntos
2-Piridinilmetilsulfinilbenzimidazóis/administração & dosagem , Refluxo Gastroesofágico/tratamento farmacológico , Aceitação pelo Paciente de Cuidados de Saúde , Cooperação do Paciente , Atenção Primária à Saúde , Inibidores da Bomba de Prótons/administração & dosagem , 2-Piridinilmetilsulfinilbenzimidazóis/farmacocinética , 2-Piridinilmetilsulfinilbenzimidazóis/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Anti-Inflamatórios não Esteroides/efeitos adversos , Estudos Transversais , Feminino , Refluxo Gastroesofágico/fisiopatologia , Humanos , Lansoprazol , Masculino , Pessoa de Meia-Idade , Inibidores da Bomba de Prótons/farmacocinética , Inibidores da Bomba de Prótons/uso terapêutico , Inquéritos e Questionários , Comprimidos
20.
Clin Drug Investig ; 27(11): 765-70, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17914895

RESUMO

OBJECTIVE: To assess the acceptability of lansoprazole orally disintegrating tablets (LODT) in patients with gastro-oesophageal reflux disease (GORD). METHODS: A multicentre, observational, cross-sectional study of patients diagnosed with GORD aged > or =18 years under the care of 272 gastroenterologists. Acceptability was determined by global patient assessment whereby the drug's organoleptic characteristics and properties were evaluated by a self-administered 11-item ad hoc questionnaire with a 5-point Likert-type scale. RESULTS: A total of 734 patients (mean age 49.6 years [SD = 15.2]) with GORD who had been prescribed LODT > or =14 days prior to inclusion in the study were evaluable for the main endpoint. Of these, 51.1% were men. Most patients (80.7%) had been treated with doses of LODT 30mg/day for an average of 52.7 days (SD = 59.3). Overall, 93.6% of patients rated LODT treatment as 'very acceptable' or ''acceptable'. The degree of acceptability was associated with the perception that the formulation helps treatment compliance (p < 0.001). The drug's properties were rated as follows: size 'neither large nor small' (70.0%); flavour 'very pleasant' or 'pleasant' (75.2%); intensity of flavour 'neither strong nor mild', 'mild' or 'very mild' (86.1%); no 'sandy sensation' (53.4%); speed of dissolving 'fast' or 'very fast' (80.2%); use of tablets 'very easy' or 'easy' (92.4%) and use of tablets 'very convenient' or 'convenient' (91.0%). Three adverse reactions, none of them serious, were reported in three patients (0.4%). CONCLUSIONS: LODT were well accepted by patients with GORD. Patients reported that this formulation improved compliance with therapy. Tolerability was excellent.


Assuntos
2-Piridinilmetilsulfinilbenzimidazóis/administração & dosagem , Refluxo Gastroesofágico/tratamento farmacológico , Aceitação pelo Paciente de Cuidados de Saúde , Inibidores da Bomba de Prótons/administração & dosagem , Administração Oral , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Feminino , Humanos , Lansoprazol , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...